Differential current thermal mass flow transducer
    4.
    发明授权
    Differential current thermal mass flow transducer 失效
    差分电流热质量流量传感器

    公开(公告)号:US5461913A

    公开(公告)日:1995-10-31

    申请号:US264706

    申请日:1994-06-23

    IPC分类号: G01F1/68 G01F1/684 G01F1/696

    CPC分类号: G01F1/6847

    摘要: The disclosed mass flow transducer is of the type including a balanced bridge comprising two, substantially identical, thermal elements forming two sides of the bridge between the top and the bottom of the bridge, the two elements being adapted to be positioned in two regions of a laminar flow tube in a symmetrical tandem arrangement so as to sense flow through the tube, one element being upstream from the other. The preferred transducer includes control means for monitoring the voltage at the top and bottom of the bridge and monitoring the current required to maintain the node between the thermal elements at virtual ground.

    摘要翻译: 所公开的质量流量传感器的类型包括平衡桥,该平衡桥包括两个基本上相同的热元件,其形成桥的顶部和底部之间的桥的两侧,两个元件适于定位在桥的两个区域中 层流管以对称串联布置,以便感测通过管的流动,一个元件在另一个的上游。 优选的换能器包括用于监测桥的顶部和底部的电压的监控装置,并且监测将虚拟地面上的热元件之间保持节点所需的电流。

    Extended release pharmaceutical dosage form
    5.
    发明申请
    Extended release pharmaceutical dosage form 审中-公开
    延长释放药物剂型

    公开(公告)号:US20050129762A1

    公开(公告)日:2005-06-16

    申请号:US10964012

    申请日:2004-10-13

    CPC分类号: A61K9/209 A61K31/137

    摘要: This invention relates to novel extended release pharmaceutical dosage forms for orally delivering drugs to mammals, e.g., humans. More particularly, this invention concerns novel dosage forms of water soluble drugs such as venlafaxine, enantiomeric (R or S) forms of venlafaxine, metabolites of venlafaxine such as O-desmethyl venlafaxine (ODV) or enantiomeric (R or S) forms of said metabolites which dosage forms have an extended release profile when taken orally. This invention also provides processes for preparing such dosage forms and methods of using them.

    摘要翻译: 本发明涉及用于向哺乳动物(例如人)口服递送药物的新型延长释放药物剂型。 更具体地说,本发明涉及水溶性药物如文拉法辛,文拉法辛的对映体(R或S)形式,文拉法辛的代谢物如O-去甲基文拉法辛(ODV)或所述代谢物的对映体(R或S))形式的新型剂型 当口服时,哪些剂型具有延长的释放特征。 本发明还提供了制备这种剂型的方法和使用它们的方法。